chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Covid positive after Pfizer vaccine; Covid positive after Pfizer vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Covid positive after Pfizer vaccine". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initial report received on 12 November 2007 from a health care professional. A 56-year-old male patient, with no illness at the time of vaccination, had received a left deltoid, intramuscular injection of FLUZONE No Preservative 2007-2008, lot number U2457DA, on 30 October 2007. The patient had received more than six previous doses of influenza vaccine. Two days post-vaccination, the patient experienced body aches, headache, swollen glands on the left side of his neck, sore throat, fluid in his left ear, and inability to sleep. He was examined by a physician and treated with unspecified oral medication. At the time of this report, the patient had not recovered. Follow-up information received on 09 January 2008. Diagnostic testing was done, and the diagnosis was unknown. The patient recovered.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unspecified date in 2003 the patient was vaccinated with a PNEUMOVAX 23 (dose, route, lot number not reported) and subsequently with a second dose of PNEUMOVAX 23 (dose, route, lot number not reported) on a unspecified date in 2004. The pharmacist reported that the patient received two doses of PNEUMOVAX 23 when the patient was under the age of 65 years old. No adverse effect reported. Additional information has been requested.
PATIENT REFERS AN INTESE ITCH THROUGHOUT THE BODY. NO RASH OR NO SWELLING WAS OBSERVED.
shingles; painful; neuropathy pain; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles, pain and post herpetic neuralgia. On an unknown date, the outcome of the shingles and pain were unknown and the outcome of the post herpetic neuralgia was not recovered/not resolved.   It was unknown if the reporter considered the shingles, pain and post herpetic neuralgia to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient took the first vaccine but got shingles. They were painful but probably could have been worse if the patient had not been vaccinated.  The patient reported that the bad part was that they sometimes return in other places and the patient had painful neuropathy.  The patient reported that, he/she received both dose of latest Shingles vaccine, but the neuropathy pain stayed with him/her. The patient was not sure if it would ever go away.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR173031:Same reporter
Vaccine expired on 03 Oct 2021 and placed in refrigerator on 04 Nov 2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 03 Oct 2021 and placed in refrigerator on 04 Nov 2021) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 03 Oct 2021 and placed in refrigerator on 04 Nov 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 03 Oct 2021 and placed in refrigerator on 04 Nov 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Vaccine placed in refrigerator on 04 Nov 2021. Vial did not undergo temperature excursion. No adverse event reported.  Treatment medications were not reported.
PATIENT REPORTS ARM WAS FINE FOR 2 WEEKS AFTER SHOT, THEN BEGAN HURTING. STILL HURTS TO TOUCH AND RANGE OF MOTION IS IMPEDED. PATIENT HAS NOT SEEN PHYSICIAN, I HAVE RECOMENDED THAT HE DOES.
Minor swollen lymph nodes were first observed on day 3 pm at the patient?s neck same side as the injection (left arm). Since then severe swollen lymph nodes have been developing on multiple areas from shoulder, along the neck, to face/back of ear, same side (left) of the shot. Sizes of some areas are more than 1 square inch. Other symptoms including, migrate, mild fever and fatigue.
Stroke; A spontaneous report was received from a Consumer and Other HCP  concerning a  84Years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event like Stroke.      The patient's medical history provided no adverse event. Relevant concomitant medications were reported like atorvastatin calcium, ezetimibe, niacin, metoprolol, acetylsalicylic acid, levothyroxine sodium, and iron supplement.  On 4th Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 038k20a) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On date 5th Feb 2021, The patient experienced the event like Stroke, which required hospitalization. It was noted the patient's speech was getting better, but the left side of his body was still paralyzed. There was no treatment information provided  There were no laboratory details provided.   Action taken with mRNA-1273 in response to the events was not reported.    The outcome of the event is unknown.; Reporter's Comments: Although a temporal association exit, provided information is not adequate to assess the causal association between the event and mRNA-1273.  Critical details such as the medical history and diagnostic report is lacking. Causality is also confounded by the patient's advanced age and suspected cardiac related condition (patient is on antihypertensive noted in conmed)
This spontaneous report as received from a health care worker refers to an unspecified number of patient of an unknown age and gender. On an unspecified date, unspecified number of patients were vaccinated with improperly stored (Oka-Merck) PROQUAD (Lot#, strength, dose route were not reported) for an unknown indication. No adverse effects reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a registered nurse and refers to unspecified patients of unknown ages and genders. There was no information about patients' concurrent conditions, medical history or concomitant medications. On multiple unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot # N012131 and expiration date of 17-APR-2019, (route of administration and anatomical location were not reported) for prophylaxis, reconstituted with properly stored sterile diluent (MERCK) (lot # unknown), The vaccines were stored in the range of 6 Fahrenheit degrees to 14 Fahrenheit degrees for 3 hours and 40 minutes. No previous temperature excursion was reported. No adverse effects were reported. Digital data logger was involved.
Six hours after her shot patients started shaking and felt hot. Went to hospital ER. They gave her Tylenol. She waited 2 hours then went home.
on 13Jul90 @ 10 am pt recvd DTP, that afternoon, mom reported a 15 sec episode of arms & legs jerking & eyes rolling back, baby brought to ofc where T of 100.4(R) noted, observed for 4 hrs /w no further episodes
The patient received the vaccine and within 2 minutes of receiving the vaccine he passed out. His eyes rolled in the back of his head and passed out in the chair. The patient was moved to the ground and came to within two minutes.
This case was reported by a consumer and described the occurrence of adverse event in a adult patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. After reporting the medical complications to the pharmacists, he said her husband was the 2nd person to have an adverse reaction. This case was linked to the case US2018GSK080294, reported by the same reporter for the other patient.
Myalgia, SkinRash & UrticariaPruritus Narrative:  11/30/2021 Moderna booster injection given with no reaction. 12/1 developed body ache and fatigue, a little red, slight swollen and itchy at injection sight, 12/2 injection site red, swollen, itchy. Ibuprofen and ice pack used, resolved 12/5/2021
Booster dose; Stomach pain; vomiting; diarrhea; Pain; Started her period, that probably makes it worse; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 38 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Booster dose"; ABDOMINAL PAIN UPPER (non-serious), outcome "unknown", described as "Stomach pain"; VOMITING (non-serious), outcome "unknown", described as "vomiting"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; PAIN (non-serious), outcome "unknown", described as "Pain"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "Started her period, that probably makes it worse".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient received the vaccine and within 5 minutes during the mandatory waiting period, the patient felt nauseous and stood up to go to the bathroom. He felt like he was going to vomit. On the way to the bathroom, the patient began to feel light headed, hearing loss, and lastly blurred vision. The patient  subsequently fell to the floor in what appeared to be syncopal episode.
Child ran fever of 101-102 F and became lethargic. Mom called MD, advised to call back if fever continues. Diarrhea started on 5/17, looser than normal then turned green with over 12 diarrhea diapers in 24 hours. Child went to MD on 5/23, dx'd with dehydration, to continue breastfeeding and Pedialyte. Went to ER on 5/24, was given IV fluids. Blood collected for testing, staff unable to get a stool specimen for testing. Mom returning to MD today, 5/28/13. Mom said child has no hx of spitting up but is now doing so.
dose given from vial that had been open for 24 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose given from vial that had been open for 24 hours) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jul-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose given from vial that had been open for 24 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose given from vial that had been open for 24 hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Information was received on 11-MAY-2017 from a pharmacist who is the patient, a female patient of unknown age. No concomitant medications or medical history was reported. The pharmacist reported that on an unknown date, while drawing up a dose of VARIVAX (lot, expiration and dose not reported), "a droplet touched my skin". The pharmacist reported that she is pregnant (gestational age not reported). No adverse effects reported. Additional information is not expected. No consent to contact the reporter.
This spontaneous report as received from a physician and from a support services director refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 10-MAR-2016, the patient was vaccinated with an improperly stored ROTATEQ 2 ml oral injection (lot# L008997, expiry date 04-DEC-2020; dose and route of administration were not reported). There were no concomitant therapies reported. The dose of the vaccine was exposed to two separate temperature excursion (dates unspecified): one lasting for 632 hours, with the lowest recorded temperature of 34 degrees Fahrenheit (1.11 degrees Celsius) and the second one lasting for 168 hours, with the lowest recorded temperature of 32 degrees Fahrenheit (0 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
I thought I was coming down with a cold. I congested, sore throat and sneezing. I was buying throat lozenges to treat the sore throat. I was on vacation when I started having symptoms.  By the time I got home I was really tired, so I decided to take an at home COVID-19 Test which lit up immediately. I called my doctor who prescribed a Z-Pack that I took for about 7 days.  I called one of the pharmacies to have and they develop residual dizziness. I was tired for a long time, and I am still dizzy. I don't know if its from COVID-19 and I have been dizzy every sense.
Patient presented to ED after having syncopal episode, denied shortness of breath of cough. Patient admitted for COVID PNA and is still undergoing inpatient treatment.
She got her vaccine, the inside of her mouth has been flaming burning, her gums are burning, bleeding, her tongue was extremely sensitive when she runs her tongue on them, and her lips are numb.  She also vertigo, if she sat up in bed she would fall over.  She went to the IC to see if she had an inner ear infection, thought her mouth issues were dental.  Went to the dentist and had her teeth cleaned and still has the issue.  Her cousin had COVID twice and developed shingles on her eyes and her sister told her to see if it was shingles as it was one of the AE to shingles.   The PCP told her to go to the dentist.  She was given exercises for the vertigo, had no ear infection, which this did go away.  She went to PCP on 12/14/21, she was still feeling dizzy after the booster with vertigo.  She felt that she had a blister that had since gone.  She did blood work CMP, CBC and diff and then had a FU with her and said that she would refer her to an ENT, but referred her to a neurologist to get some tests done.  The neurologist ruled out Parkinson's, saw some lesions in her mouth and was given a list of tests she was to get, an MRI, etc., but she has not done those yet.  She then saw her PCP on 2/16/22 and felt that she may have thrush and they would not swab her mouth.  She has been using apple cider, still had the numbness.  She then wondered if her symptoms were related to the vaccine and prescribed to see the neurologist.  She is now trying to get a test for shingles.  None of her problems have resolved, have not given her any diagnosis but can see an oral surgeon, which she would have to pay for that and does not have the money to do the testing.    She requested from her doctor to see how she could see if she had shingles or not, and has not heard back from her yet.
pt recvd flu vax & devel a sterile abscess, which was treated w/ATB, incision, & drainage; abscess resolved, however, recurred approx 6 months later; pt is to undergo lancing of the sterile abscess again;
Swollen right arm. Sq of softball. Warm to touch. Patient was given alternative shot schedule to follow due to him getting pancreas out in Jan. 2015.
This spontaneous report as received from a medical assistant, concerning unspecified number of patients of unknown ages and genders. The patients' medical history, concurrent conditions and concomitant medications were not provided. On an unknown dates, the patients were vaccinated with an improperly stored doses of M-M-R II lot # M015931 and expiration date 30-MAR-2018 (dose, frequency and route of administration were not provided) for prophylaxis which was reconstituted with a properly stored dose of sterile diluent. Furthermore, the patients were vaccinated with an improperly stored doses of GARDASIL 9 lot #N013276 with expiration date 21-JAN-2020 (dose, frequency and route of administration were not provided) and ROTATEQ orally, lot # M041768 with expiration date 25-JUN-2018 (dose and frequency were not provided). The vaccine of M-M-R II was stored at a temperature and time frame of 47 Fahrenheit to 77 Fahrenheit (48 Fahrenheit) for 1 hour and 25 minutes, previous temperature excursion of 47 Fahrenheit to 77 Fahrenheit (53 Fahrenheit) for 2 hours, 35 Minutes. Digital Data logger was involved. The vaccine of GARDASIL 9 and ROTATEQ were stored at a temperature and time frame of 47 Fahrenheit to 77 Fahrenheit (48 Fahrenheit) for 1 hour, 25 minutes, no previous temperature excursion. Digital Data logger was involved.
This case was reported by a physician (also the subject) via a sales representative and described the occurrence of a young adult female subject of unspecified age not responding to therapy following vaccination with hepatitis B vaccine recombinant (Hepatitis B vaccine, manufacturer unspecified).  On unspecified dates the subject completed the hepatitis B vaccination series and did not respond to therapy.  The subject then completed a 2nd hepatitis B vaccination series (dates not known) and still did not respond.  The outcome of event was not reported.
This spontaneous report as received from a medical assistant refers to multiple patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medications, drug reactions, or allergies was provided. On unknown dates, the patients might be vaccinated with improperly stored doses of VARIVAX injection (lot # M037642; expiration date: 01-SEP-2018; dose and route of administration were not provided). No adverse effects were reported. Administered doses of vaccine experienced the temperature excursion of above -15 degrees Celsius, but below -10 degrees Celsius for 7 hours and 14 minutes and above -10 degrees Celsius, but below -8 degrees Celsius for 2 hours and 38 minutes. There was no previous temperature excursions. Digital data logger was involved. Additional information has been requested.
5/23 patient exhibited 3 cm firm red spot, hot to touch at site of Varivax injection
Drowsiness; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 02Apr2021, for COVID-19 immunization. The following information was reported: SOMNOLENCE (non-serious) with onset Apr2021, outcome "unknown", described as "Drowsiness"; HEADACHE (non-serious) with onset Apr2021, outcome "unknown", described as "Headache".  Additional Information: After the 2nd dose, patient is having drowsiness and a headache. Patient asked if he can take Tylenol or Advil.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from physician, via the patient's mother, who reported that her daughter was vaccinated with a dose of GARDASIL. Subsequently the patient experienced renal failure and was hospitalized. The physician thought renal failure was possibly related to GARDASIL. No outcome was reported. This is one of several reports received from the same source. Additional information has been requested.
injury; This case was reported by a consumer via interactive digital media and described the occurrence of injury in a child female patient who received HPV 16-18 (HPV vaccine) for prophylaxis.   On an unknown date, the patient received HPV vaccine at an unknown dose. On an unknown date, unknown after receiving HPV vaccine, the patient experienced injury. On an unknown date, the outcome of the injury was unknown.   It was unknown if the reporter considered the injury to be related to HPV vaccine.  Additional details were provided as follows: The age at vaccination was not provided. The patient was injured by the HPV vaccine as well. The reported stated that people just don't understand until it's their child.
So on Saturday 9/10/22 I felt worn down and had a headache and just thought I was having effects from the vaccines.  It felt just groggy and tired.  On Sunday I felt congestion with lower back pain and headache.  I had to use a heating pad for my back.  I was also sneezing a lot and the next day I felt like my back pain was getting better but I still congested and sneezing a lot with watery eyes.  So on Monday my ears were hurting and tired and then on Tuesday I was having a sore throat with a dry cough and congestion with either a stopped up nose or running with sneezing feeling similar to a chest cold with allergies. Today I am doing better but I have watery eyes. sore throat, headache.  I sought treatment on Monday 9/12/22 I took a home COVID-19 test and it was positive.  My employer requested a PCR test and I went and got tested and was positive and I was advised to drink more fluids because my heart rate was elevated from the nurse practitioner.
Tinnitus is very bad. Arthritis in joints and hands. My hads feel like they are blown up like a ballon. I ache all over.
This is a spontaneous report from a contactable mother reporting on behalf of her son. A male patient (age unknown) received a dose of PREVNAR 13 on an unknown date. Relevant medical history includes an allergy to any derivatives of soy. Concomitant medications were not provided. On an unspecified date, the patient experienced colitis. On an unknown date the patient had a reaction to the PREVNAR 13 (reaction not further specified). The patient's mother further inquired about PREVNAR 13 containing soy proteins, coconut oil, or any coconut derivative. The mother noted that she confirmed with medical facility that PREVNAR 13 has derivatives of soy and that it should be labeled properly. The outcome of the event was unknown. Follow-up (12Aug2011): Follow-up attempts completed. No further information expected. Follow-up (30Aug2011): New information reported from the contactable consumer includes: medical history.
C/O DIZZY AND SENSATION OF THROAT CLOSING, CODE GREEN CALLED, SX RESOLVED, REFUSED TRANSPORT.